{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:51:22Z","timestamp":1781700682923,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Foundation of the Hebei Provincial Department of Education Degree Office Graduate Innovation Funding Project for Higher Education Institutions","award":["XCXZZB202307"],"award-info":[{"award-number":["XCXZZB202307"]}]},{"name":"The Hebei Provincial Medical Applicable Technology Tracking Project","award":["GZ2022048"],"award-info":[{"award-number":["GZ2022048"]}]},{"name":"The Health Commission Foundation of Hebei Province","award":["20230818"],"award-info":[{"award-number":["20230818"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04469-4","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T18:15:14Z","timestamp":1719512114000},"page":"4531-4542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of 68Ga-FAPI-04 and 18F-FDG PET\/CT in diagnosing ovarian cancer"],"prefix":"10.1007","volume":"49","author":[{"given":"Yunuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenglian","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7060-2643","authenticated-orcid":false,"given":"Xinming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"issue":"3","key":"4469_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4469_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41392-020-0199-6","volume":"5","author":"Q Wang","year":"2020","unstructured":"Wang Q, Peng H, Qi X, Wu M, Zhao X (2020) Targeted therapies in gynecological cancers: a comprehensive review of clinical evidence. Signal Transduct Target Ther 5(1):137. https:\/\/doi.org\/10.1038\/s41392-020-0199-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"4469_CR3","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/cancers14092230","volume":"14","author":"J Huang","year":"2022","unstructured":"Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE 3rd, Xu W, Zheng ZJ, Elcarte E, Withers M, Wong M, Apru OBONGHRGOAOPRU (2022) Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers (Basel) 14(9):2230. https:\/\/doi.org\/10.3390\/cancers14092230.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4469_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/uog.17557","volume":"51","author":"KB Mathieu","year":"2018","unstructured":"Mathieu KB, Bedi DG, Thrower SL, Qayyum A, Bast RC Jr (2018) Screening for ovarian cancer: imaging challenges and opportunities for improvement. Ultrasound Obstet Gynecol 51(3):293\u2013303. https:\/\/doi.org\/10.1002\/uog.17557.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"4469_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/ijgo.13878","volume":"155 Suppl","author":"JS Berek","year":"2021","unstructured":"Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M (2021) Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet 155 Suppl:61\u201385. https:\/\/doi.org\/10.1002\/ijgo.13878.","journal-title":"Int J Gynaecol Obstet"},{"key":"4469_CR6","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3389\/fonc.2019.01537","volume":"9","author":"S Nimmagadda","year":"2019","unstructured":"Nimmagadda S, Penet MF (2019) Ovarian Cancer Targeted Theranostics. Front Oncol 9:1537. https:\/\/doi.org\/10.3389\/fonc.2019.01537.","journal-title":"Front Oncol"},{"issue":"23","key":"4469_CR7","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1056\/NEJMoa2103294","volume":"385","author":"P Harter","year":"2021","unstructured":"Harter P, Sehouli J, Vergote I, Ferron G, Reuss A, Meier W, Greggi S, Mosgaard BJ, Selle F, Guyon F, Pomel C, L\u00e9curu F, Zang R, Avall-Lundqvist E, Kim JW, Ponce J, Raspagliesi F, Kristensen G, Classe JM, Hillemanns P, Jensen P, Hasenburg A, Ghaem-Maghami S, Mirza MR, Lund B, Reinthaller A, Santaballa A, Olaitan A, Hilpert F, du Bois A (2021) Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer. N Engl J Med 385(23):2123\u20132131. https:\/\/doi.org\/10.1056\/NEJMoa2103294.","journal-title":"N Engl J Med"},{"issue":"10","key":"4469_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12149-023-01856-7","volume":"37","author":"X Li","year":"2023","unstructured":"Li X, Wang L, Guo P, Sun Q, Zhang Y, Chen C, Zhang Y (2023) Diagnostic performance of noninvasive imaging using computed tomography, magnetic resonance imaging, and positron emission tomography for the detection of ovarian cancer: a meta-analysis. Ann Nucl Med 37(10):541\u2013550. https:\/\/doi.org\/10.1007\/s12149-023-01856-7.","journal-title":"Ann Nucl Med"},{"issue":"6","key":"4469_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s00261-008-9464-9","volume":"35","author":"D Marin","year":"2010","unstructured":"Marin D, Catalano C, Baski M, Di Martino M, Geiger D, Di Giorgio A, Sibio S, Passariello R (2010) 64-Section multi-detector row CT in the preoperative diagnosis of peritoneal carcinomatosis: correlation with histopathological findings. Abdom Imaging 35(6):694\u2013700. https:\/\/doi.org\/10.1007\/s00261-008-9464-9.","journal-title":"Abdom Imaging"},{"issue":"6","key":"4469_CR10","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.3390\/cancers15061904","volume":"15","author":"P Pinto","year":"2023","unstructured":"Pinto P, Burgetova A, Cibula D, Haldorsen IS, Indrielle-Kelly T, Fischerova D (2023) Prediction of Surgical Outcome in Advanced Ovarian Cancer by Imaging and Laparoscopy: A Narrative Review. Cancers (Basel) 15(6):1904. https:\/\/doi.org\/10.3390\/cancers15061904.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"4469_CR11","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/aogs.14442","volume":"101","author":"J Wang","year":"2022","unstructured":"Wang J, Liu L, Pang H, Liu L, Jing X, Li Y (2022) Preoperative PET\/CT score can predict incomplete resection after debulking surgery for advanced serous ovarian cancer better than CT score, MTV, tumor markers and hematological markers. ACTA OBSTET GYN SCAN 101(11):1315\u20131327. https:\/\/doi.org\/10.1111\/aogs.14442.","journal-title":"ACTA OBSTET GYN SCAN"},{"key":"4469_CR12","doi-asserted-by":"publisher","unstructured":"Delgado Bolton RC, Aide N, Colletti PM, Ferrero A, Paez D, Skanjeti A, Giammarile F (2021) EANM guideline on the role of 2-[18F]FDG PET\/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA). Eur J Nucl Med Mol Imaging 48(10):3286\u20133302. https:\/\/doi.org\/10.1007\/s00259-021-05450-9.","DOI":"10.1007\/s00259-021-05450-9"},{"key":"4469_CR13","doi-asserted-by":"publisher","first-page":"109168","DOI":"10.1016\/j.biopha.2019.109168","volume":"117","author":"WT Rahman","year":"2019","unstructured":"Rahman WT, Wale DJ, Viglianti BL, Townsend DM, Manganaro MS, Gross MD, Wong KK, Rubello D (2019) The impact of infection and inflammation in oncologic (18)F-FDG PET\/CT imaging. Biomed Pharmacother 117:109168. https:\/\/doi.org\/10.1016\/j.biopha.2019.109168.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"4469_CR14","doi-asserted-by":"publisher","first-page":"490","DOI":"10.2214\/AJR.22.28402","volume":"220","author":"G Zhao","year":"2023","unstructured":"Zhao G, Wang X, Ji B (2023) Head-To-Head Comparison of 68Ga-FAPI PET\/CT and FDG PET\/CT for the Detection of Peritoneal Metastases: Systematic Review and Meta-Analysis. AJR Am J Roentgenol 220(4):490\u2013498. https:\/\/doi.org\/10.2214\/AJR.22.28402.","journal-title":"AJR Am J Roentgenol"},{"issue":"Pt 3","key":"4469_CR15","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.semcancer.2022.04.008","volume":"86","author":"A Peltier","year":"2022","unstructured":"Peltier A, Seban RD, Buvat I, Bidard FC, Mechta-Grigoriou F (2022) Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging. Semin Cancer Biol 86(Pt 3):262\u2013272. https:\/\/doi.org\/10.1016\/j.semcancer.2022.04.008.","journal-title":"Semin Cancer Biol"},{"key":"4469_CR16","doi-asserted-by":"publisher","first-page":"103729","DOI":"10.1016\/j.cellimm.2017.12.003","volume":"343","author":"Z Liao","year":"2019","unstructured":"Liao Z, Tan ZW, Zhu P, Tan NS (2019) Cancer-associated fibroblasts in tumor microenvironment-Accomplices in tumor malignancy. Cell Immunol 343:103729. https:\/\/doi.org\/10.1016\/j.cellimm.2017.12.003.","journal-title":"Cell Immunol"},{"issue":"6","key":"4469_CR17","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, Adeberg S, Rathke H, R\u00f6hrich M, Winter H, Plinkert PK, Marme F, Lang M, Kauczor HU, J\u00e4ger D, Debus J, Haberkorn U, Giesel FL (2019) 68Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med 60(6):801\u2013805. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"issue":"8","key":"4469_CR18","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00259-022-05818-5","volume":"49","author":"X Zhou","year":"2022","unstructured":"Zhou X, Wang S, Xu X, Meng X, Zhang H, Zhang A, Song Y, Zhu H, Yang Z, Li N (2022) Higher accuracy of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT comparing with 2-[(18)F]FDG PET\/CT in clinical staging of NSCLC. Eur J Nucl Med Mol Imaging 49(8):2983\u20132993. https:\/\/doi.org\/10.1007\/s00259-022-05818-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"4469_CR19","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s00330-022-09251-y","volume":"33","author":"C Li","year":"2023","unstructured":"Li C, Tian Y, Chen J, Jiang Y, Xue Z, Xing D, Wen B, He Y (2023) Usefulness of [(68)Ga]FAPI-04 and [(18)F]FDG PET\/CT for the detection of primary tumour and metastatic lesions in gastrointestinal carcinoma: a comparative study. Eur Radiol 33(4):2779\u20132791. https:\/\/doi.org\/10.1007\/s00330-022-09251-y.","journal-title":"Eur Radiol"},{"issue":"6","key":"4469_CR20","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, Sun L, Wu H, Lin Q, Chen H (2021) Role of [(68)Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [(18)F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging 48(6):1944\u20131955. https:\/\/doi.org\/10.1007\/s00259-020-05146-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4469_CR21","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1007\/s00330-022-09321-1","volume":"33","author":"Y Miao","year":"2023","unstructured":"Miao Y, Feng R, Guo R et al (2023) Utility of [(68)Ga]FAPI-04 and [(18)F]FDG dual-tracer PET\/CT in the initial evaluation of gastric cancer. Eur Radiol 33:4355\u20134366. https:\/\/doi.org\/10.1007\/s00330-022-09321-1.","journal-title":"Eur Radiol"},{"key":"4469_CR22","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00259-022-06096-x","volume":"50","author":"S Liu","year":"2023","unstructured":"Liu S, Feng Z, Xu X et al (2023) Head-to-head comparison of [(18)F]-FDG and [(68)Ga]-DOTA-FAPI-04 PET\/CT for radiological evaluation of platinum-sensitive recurrent ovarian cancer. Eur J Nucl Med Mol Imaging 50:1521\u20131531. https:\/\/doi.org\/10.1007\/s00259-022-06096-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4469_CR23","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2967\/jnumed.120.258467","volume":"63","author":"C Qin","year":"2022","unstructured":"Qin C, Shao F, Gai Y et al (2022) (68)Ga-DOTA-FAPI-04 PET\/MR in the Evaluation of Gastric Carcinomas: Comparison with (18)F-FDG PET\/CT. J Nucl Med 63:81\u201388. https:\/\/doi.org\/10.2967\/jnumed.120.258467.","journal-title":"J Nucl Med"},{"issue":"1","key":"4469_CR24","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221(1):29\u201342. https:\/\/doi.org\/10.1097\/00000658-199501000-00004.","journal-title":"Ann Surg"},{"issue":"5","key":"4469_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00432-024-05707-4","volume":"150","author":"Y Wei","year":"2024","unstructured":"Wei Y, Cai J, Wang L, Yang J, Li Y, Li X, Zhang X, Shi Y, Tang L (2024) Dynamic change in the peritoneal cancer index based on CT after chemotherapy in the overall survival prediction of gastric cancer patients with peritoneal metastasis. J CANCER RES CLIN 150 (5):222. https:\/\/doi.org\/10.1007\/s00432-024-05707-4.","journal-title":"J CANCER RES CLIN"},{"issue":"3","key":"4469_CR26","doi-asserted-by":"publisher","first-page":"e141-e150","DOI":"10.1097\/RLU.0000000000003489","volume":"46","author":"P Sharma","year":"2021","unstructured":"Sharma P, Singh SS, Gayana S (2021) Fibroblast Activation Protein Inhibitor PET\/CT: A Promising Molecular Imaging Tool. Clin Nucl Med 46(3):e141-e150. https:\/\/doi.org\/10.1097\/RLU.0000000000003489.","journal-title":"Clin Nucl Med"},{"key":"4469_CR27","doi-asserted-by":"publisher","unstructured":"Wang Q, Yang S, Tang W, Liu L, Chen Y (2021) (68)Ga-DOTA-FAPI-04 PET\/CT as a Promising Tool for Differentiating Ovarian Physiological Uptake: Preliminary Experience of Comparative Analysis With (18)F-FDG. Front Med (Lausanne) 8:748683. https:\/\/doi.org\/10.3389\/fmed.2021.748683.","DOI":"10.3389\/fmed.2021.748683"},{"issue":"3","key":"4469_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2967\/jnumed.122.264544","volume":"64","author":"Y Pang","year":"2022","unstructured":"Pang Y, Zhao L, Meng T, Xu W, Lin Q, Wu H, Zhang J, Chen X, Sun L, Chen H (2022) PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study. J NUCL MED 64(3):386\u2013394. https:\/\/doi.org\/10.2967\/jnumed.122.264544.","journal-title":"J NUCL MED"},{"issue":"5","key":"4469_CR29","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/ijgc-2023-005158","volume":"34","author":"C Sanson","year":"2024","unstructured":"Sanson C, Roosen A, Faron M, Zaccarini F, Maulard A, Scherier S, Pautier P, Leary A, Chargari C, Espenel S, Genestie C, Morice P, Gouy S (2024) Correlation between peritoneal cancer index and survival in advanced epithelial ovarian cancer with complete resection. Int J Gynecol Cancer 34(5):730\u2013737. https:\/\/doi.org\/10.1136\/ijgc-2023-005158.","journal-title":"Int J Gynecol Cancer"},{"issue":"13","key":"4469_CR30","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1007\/s00259-023-06369-z","volume":"50","author":"J Chen","year":"2023","unstructured":"Chen J, Xu K, Li C, Tian Y, Li L, Wen B, He C, Cai H, He Y (2023) [(68)Ga]Ga-FAPI-04 PET\/CT in the evaluation of epithelial ovarian cancer: comparison with [(18)F]F-FDG PET\/CT. Eur J Nucl Med Mol Imaging 50(13):4064\u20134076. https:\/\/doi.org\/10.1007\/s00259-023-06369-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"4469_CR31","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MNM.0000000000001653","volume":"44","author":"W Zheng","year":"2023","unstructured":"Zheng W, Liu L, Feng Y, Wang L, Chen Y (2023) Comparison of 68Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET\/computed tomography in the detection of ovarian malignancies. Nucl Med Commun 44(3):194\u2013203. https:\/\/doi.org\/10.1097\/MNM.0000000000001653.","journal-title":"Nucl Med Commun"},{"issue":"3","key":"4469_CR32","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00259-021-05522-w","volume":"49","author":"L Lan","year":"2022","unstructured":"Lan L, Liu H, Wang Y, Deng J, Peng D, Feng Y, Wang L, Chen Y, Qiu L (2022) The potential utility of [(68)Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent-comparison with [(18)F]FDG. Eur J Nucl Med Mol Imaging 49(3):963\u2013979. https:\/\/doi.org\/10.1007\/s00259-021-05522-w.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04469-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04469-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04469-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:08:18Z","timestamp":1730200098000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04469-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4469"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04469-4","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]},"assertion":[{"value":"11 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained in accordance with the standards set forth by hospital regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or fnancial relationships that could be construed as a potential confict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}